Rath W
Frauenklinik für Gynäkologie und Geburtshilfe der RWTH Aachen.
Geburtshilfe Frauenheilkd. 1996 Jun;56(6):265-71. doi: 10.1055/s-2007-1023024.
The HELLP syndrome is a severe and life-threatening form of preeclampsia associated with typical laboratory findings. The major problems are the fluctuating course of the disease, the unpredictable occurrence of severe maternal complications and the high maternal and perinatal mortality. Time-limited reversal of the laboratory parameters has been observed in 20-40% of cases; however, the majority of patients shows a deterioration of the disease within 1-10 days. As no reliable clinical and laboratory indicators exist, as well as no precisely defined cut-off values in predicting the course and prognosis, the outcome of the HELLP syndrome is unpredictable. The high maternal morbidity and mortality are mainly due to the development of disseminated intravascular coagulation (DIC); the frequency of DIC has been shown to increase significantly with the time interval between diagnosis and delivery. The management of the HELLP syndrome has been controversial, with some authors recommending a conservative approach to induce fetal maturity in pregnancies below the 32nd (34th) week of gestation, whereas the majority recommend immediate delivery by Caesarean section in patients with an unfavourable cervix irrespective of the gestational age. It is generally agreed that early diagnosis by laboratory screening methods is mandatory and that patients with the HELLP syndrome should be transferred to a perinatal centre. A literature review since 1990 clearly demonstrates that aggressive management is associated with a significant reduction in maternal and perinatal mortality. We believe that conservative management is only justified in cases of fetal immaturity under the following conditions: no evidence of progression of the disease, no suspected or manifest DIC, fetal wellbeing and intensive monitoring of the patient in a specialised obstetric care unit cooperating closely with experienced neonatologists and anaesthesiologists.
HELLP综合征是一种与典型实验室检查结果相关的严重且危及生命的子痫前期形式。主要问题在于疾病病程波动、严重母体并发症的不可预测发生以及高母体和围产儿死亡率。20% - 40%的病例观察到实验室参数有时间限制的逆转;然而,大多数患者在1 - 10天内病情恶化。由于不存在可靠的临床和实验室指标,以及在预测病程和预后方面没有精确界定的临界值,HELLP综合征的结局无法预测。高母体发病率和死亡率主要归因于弥散性血管内凝血(DIC)的发展;已表明DIC的发生率随着诊断与分娩之间的时间间隔显著增加。HELLP综合征的管理一直存在争议,一些作者建议对于妊娠低于32(34)周的孕妇采用保守方法以促进胎儿成熟,而大多数人建议对于宫颈条件不佳的患者无论孕周大小均立即行剖宫产分娩。普遍认为通过实验室筛查方法进行早期诊断是必要的,并且HELLP综合征患者应转至围产中心。自1990年以来的文献综述清楚地表明积极管理与显著降低母体和围产儿死亡率相关。我们认为在以下情况下保守管理仅适用于胎儿不成熟的病例:无疾病进展证据、无疑似或明显的DIC、胎儿状况良好以及在与经验丰富的新生儿科医生和麻醉医生密切合作的专业产科护理单元对患者进行强化监测。